These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9785702)

  • 1. The Canadian experience with risperidone for the treatment of schizophrenia: an overview.
    Iskedjian M; Hux M; Remington GJ
    J Psychiatry Neurosci; 1998 Sep; 23(4):229-39. PubMed ID: 9785702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
    Pajonk FG
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting injectable risperidone.
    Ehret MJ; Fuller MA
    Ann Pharmacother; 2004 Dec; 38(12):2122-7. PubMed ID: 15522979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of atypical antipsychotics for the management of schizophrenia.
    Sprague DA; Loewen PS; Raymond CB
    Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience and management considerations with long-acting risperidone.
    Parellada E
    Curr Med Res Opin; 2006 Feb; 22(2):241-55. PubMed ID: 16466596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC; Lung FW; Chong MY
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract]   [Full Text] [Related]  

  • 16. [Schizophrenia and quality of life--new definition of therapeutic targets].
    Fortschr Neurol Psychiatr; 1997 Nov; 65(11 Suppl Schizophre):1-4. PubMed ID: 9431352
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperprolactinaemia induced by risperidone.
    Chung YC; Eun HB
    Int J Neuropsychopharmacol; 1998 Jul; 1(1):93-94. PubMed ID: 11281951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report on Canadian research activity in schizophrenia. Canadian Alliance for Research on Schizophrenia (CAROS).
    Brintnell ES
    J Psychiatry Neurosci; 1994 Nov; 19(5 Suppl 1):43-8. PubMed ID: 7803381
    [No Abstract]   [Full Text] [Related]  

  • 19. Risperidone induced angioedema with concurrent EPS symptoms: a case report and review of literature.
    Samra GS; Kant S; Chow R
    J Community Hosp Intern Med Perspect; 2018; 8(2):80-83. PubMed ID: 29686794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms.
    Lee J; Takeuchi H; Fervaha G; Sin GL; Foussias G; Agid O; Farooq S; Remington G
    Focus (Am Psychiatr Publ); 2016 Jul; 14(3):396-402. PubMed ID: 31997961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.